Page 1 of 1

Anyone with Kras and her2 mutations?

Posted: Thu Sep 20, 2018 9:58 am
by supportingsister
My sister was officially rejected for the hai pump at msk yestwrsay because of a 3mm nodule in her lung. She has several under 1cm mets on her liver that responded poorly to the last round of chemo.

She has a Kras and Her2 mutation. According to dr Epstein, it disqualified her for several current clinical trials. I’ve been looking at dr Lin and the adapt protocol and maybe Md Anderson?

Any suggestions on next steps and who to talk to are appreciated.

I’ll add a signature today to better understand her history. But right now Im looking for oncologists who are aggressive and are good with atypical mutations

Thank you

Re: Anyone with Kras and her2 mutations?

Posted: Thu Sep 20, 2018 2:43 pm
by NHMike
This is the only HER2 clinical trial that I found.

http://targetedcancercare.massgeneral.o ... extID=2887

Re: Anyone with Kras and her2 mutations?

Posted: Fri Sep 21, 2018 1:07 pm
by rp1954
I replied to your PM but it is unopened.

There are a lot of lab studies that show various flavonoids reduce overexpression of ErbB2/HER2 in cancer cells and related pathways, or killing them, mostly for breast cancer. For over sixty years there has been been argumentation between ascorbate and flavonoids purists about vitamin C and cancer. My answer is well duh, use them all in their cheapest forms in sensitive cells.

In some papers, flavonoids and vitamin C are shown re-sensitizing CRC to 5FU, including real patients. Vitamin C is published as a KRAS/BRAF cell killer. In real life we found we needed 5FU-LV and Vitamin C + K2. We have been using various flavonoids since the beginning. I might advocate (at least) 1-2 of the highest strength cap for each flavonoid you choose (can find or swallow), half dozen or more flavonoids. Perhaps 3-5 core flavonoids, like EGCG, quercetin, curcumin, silymarin, resveratrol, and 2-3 rotating ones, perhaps depending on supplies and availablity or even specials.

I think Dr. Lin's ADAPT work is important with some great results (e.g. stage IV patients starting ~20 years ago with median OS over 8 years), but needs more. We definitely didn't stop for addons to oral 5FU and celecoxib(Celebrex) rather padding out, carefully selecting and testing from the Life Extension lists of off label drugs and high potency supplements. Best of all about virtual (self) trials, enrollment always seems to be open and treatments flexible, less argument with insurance (for low cost cash items, out of pocket anyway).